The One Question That Paused a Healthtech Pilot
A Hyderabad startup built an AI tool that drafts session notes for American speech and behavioral therapists. The therapist records a session summary, and within a minute a structured note is ready for review. The team landed a pilot with a 12-clinic therapy group in Texas, and the therapists loved it. Then the group’s compliance officer asked a single question: where does the audio go, and who in India can access it?
The honest answer was that recordings went to a general-purpose AI service under its standard terms, and several engineers in Hyderabad could open any of them for debugging. There was no business associate agreement anywhere in the chain. The pilot was paused that afternoon.
Why US Therapy Practices Draw Indian Builders
The opportunity is easy to see. Therapists in the US, particularly in applied behavior analysis, speech, and occupational therapy, spend hours each week on documentation. ABA providers record detailed session data that insurers review before approving more hours. Every note that takes 20 minutes to write is time a clinician isn’t spending with a child.
Indian teams bring real advantages. Engineering costs are lower, and India already has a large medical billing and coding industry, so many founders have worked with US insurance claims and clinical documentation for years. They understand the paperwork better than many US startups do.
What they sometimes underestimate is how much of the sale depends on compliance rather than product quality.
What “HIPAA-Ready” Actually Requires
There’s no official certification that makes software HIPAA-compliant. When buyers ask for HIPAA-compliant AI tools, they’re asking whether you’ve put the required safeguards in place and signed the right agreements, all the way down the chain.
That chain is where the Hyderabad startup failed. The startup signs a business associate agreement with the clinic. But it also needs equivalent agreements with every vendor that touches patient data on its behalf: the cloud host, the transcription service, and the AI model provider. That model provider must contractually agree not to retain the data or use it to train future models. A standard consumer or developer account rarely includes those terms.
Access controls come next. Engineers in India shouldn’t be able to open real patient recordings for routine debugging. Development and testing should use de-identified or synthetic data. Production access should be limited to a few named people, logged, and reviewed. Patient data should never land on laptops.
Expect a long security questionnaire from any serious buyer, and expect larger clinic groups to ask for an independent security audit report before signing. If you also serve Indian patients, the Digital Personal Data Protection Act adds its own consent and data handling rules.
My strong advice: design all of this into the architecture before the first pilot. Retrofitting compliance after a buyer asks costs months and, often, the deal.
Fitting Into the Platforms Clinics Already Use
ABA and therapy practices typically run their scheduling, data collection, and billing on established practice management platforms. A note-drafting tool that doesn’t write into those systems forces therapists to copy and paste, and adoption dies within a few weeks.
CentralReach pricing is a useful reference point for founders here. Like many platforms in this category, it generally isn’t published as a simple price list and is quoted based on practice size and the modules chosen. The practical takeaway is that clinics are already paying a meaningful amount for their core system, and any new tool has to justify its cost on top of that. Before building, find out whether the platform your target clinics use offers integration access, and on what partnership terms.
Pricing Your Own Tool
Per-clinician monthly pricing is the most common model, and it’s easiest to sell when tied to time saved. If a tool saves a therapist four hours of documentation a week, and the practice values that time at $40 an hour, the math gives a clinic owner a clear ceiling. Price well below it. Owners discount vendor promises heavily until they see results across a full billing cycle.
The Hyderabad startup spent three months rebuilding. It moved to a model provider willing to sign a business associate agreement, locked down production access, and switched its developers to synthetic data. The Texas pilot resumed. The founders say the compliance officer’s question was the most useful piece of product feedback they received all year, even if it didn’t feel that way the afternoon she asked it.
Comments are closed.